INVESTOR NEWS

Mar 28, 2025

Gentian Diagnostics strengthens commercial capabilities with key appointments

Moss 28 March, 2025

Mar 21, 2025

Gentian Diagnostics: Annual report 2024

Moss, 21 March 2025 Gentian Diagnostics has today published its annual report for 2024. The annual report and..

Mar 19, 2025

Gentian Diagnostics Receives Notice of Allowance for NT-proBNP Assay Patent in Japan

Moss, 19 March 2025

Mar 12, 2025

Key information relating to the proposed cash dividend

Moss, 12 March 2025

Mar 10, 2025

Gentian Diagnostics and Beckman Coulter Partner to Launch Gentian GCAL® Calprotectin Immunoassay

Moss,10 March 2025

Mar 03, 2025

Mandatory notification of trade

Moss, 3 March 2025

Mar 03, 2025

Notification of trade

Moss, 3 March 2025

Mar 03, 2025

Disclosure of large shareholding in Gentian Diagnotics ASA

Gentian Diagnostics ASA - Disclosure of Large Shareholding Oslo, Norway, March 3, 2025

Mar 03, 2025

Disclosure of shareholdings – Holta Invest AS (2025)

3 March 2025

Feb 12, 2025

Fourth quarter 2024 report

Moss, 12 February 2025